Skip to main content
OpenTrials

Clinical trial discovery

Find Clinical Trials

Search studies by condition, treatment, location, eligibility, or trial identifier.

Showing 1–20 of 65 trials

Active filters

Clinical trials found

Published and searchable clinical trials

Searching for clinical trials...
Recruiting

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

NCT07007312

Conditions
Acute Myeloid Leukemia (AML), Hematologic Diseases, Hematologic Neoplasms, +7 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • University of California, Fresno Clovis, California, United States
  • University of California, San Diego La Jolla, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
View all 106 locations
View Trial Details
Recruiting

A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML)

NCT05756777

Conditions
Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk-Commack Commack, New York, United States
View Trial Details
Recruiting

Ivosidenib as Post-HSCT Maintenance for AML

NCT06707493

Conditions
Acute Myeloid Leukemia (AML), Hematologic Diseases, Hematopoietic Stem Cell Transplant (HSCT), +7 more
Locations
  • Emory University Hospital Atlanta, Georgia, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Ohio State University Wexner Medical Center- James Cancer Hospital Columbus, Ohio, United States
View Trial Details
Recruiting

A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)

NCT06773208

Conditions
Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Memorial Sloan Kettering at Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)

NCT06950034

Conditions
Acute Monocytic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia (AML), +24 more
Locations
  • Stanford University Stanford, California, United States
  • Moffitt Tampa, Florida, United States
  • DFCI Boston, Massachusetts, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Recruiting

APVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AML

NCT06634394

Conditions
Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • University of Miami Miami, Florida, United States
  • University of Kansas Fairway, Kansas, United States
  • Gabrail Cancer Center Canton, Ohio, United States
View Trial Details
Recruiting

Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML

NCT02781883

Conditions
Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • Georgia Cancer Center at Augusta University Augusta, Georgia, United States
  • University of Kansas Cancer Center Fairway, Kansas, United States
  • New Jersey Hematology Oncology Associates Brick, New Jersey, United States
View Trial Details
Completed

A Study of ASP2215 (Gilteritinib) by Itself, ASP2215 Combined With Azacitidine or Azacitidine by Itself to Treat Adult Patients Who Have Recently Been Diagnosed With Acute Myeloid Leukemia With a FLT3 Gene Mutation and Who Cannot Receive Standard Chemotherapy

NCT02752035

Conditions
Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation, Hematologic Diseases, +6 more
Locations
  • UCLA David Geffen School of Medicine Los Angeles, California, United States
  • University of California, Irvine Medical Center Orange, California, United States
  • Robert H. Lurie Comprehensive Cancer Center Chicago, Illinois, United States
  • Rush University Medical Center Chicago, Illinois, United States
View all 111 locations
View Trial Details
Completed

A Study of Oral Venetoclax Tablets and Oral Azacitidine as Maintenance Therapy in Adult Participants With Acute Myeloid Leukemia in First Remission After Conventional Chemotherapy

NCT04102020

Conditions
Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Mitchell Cancer Institute /ID# 216443 Mobile, Alabama, United States
  • Compassionate Cancer Care Research Group - Fountain Valley /ID# 216156 Fountain Valley, California, United States
  • University of California, Los Angeles /ID# 219149 Los Angeles, California, United States
  • Colorado Blood Cancer Institute /ID# 214280 Denver, Colorado, United States
View all 156 locations
View Trial Details